Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novel TB Prevention Regimens for HIV-Infected Adults
NCT00057122Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Sep 2002
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rifapentine, rifampicin in Tuberculosis (TB), sponsored by National Institute of Allergy and Infectious Diseases. Started Sep 2002; status: completed.
02
Drugs
rifapentinerifampicin
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT00057122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00057122.